HealthLeaders Media August 18, 2023
KFF Health News

America’s pharmaceutical giants are suing this summer to block the federal government’s first effort at drug price regulation.

KEY TAKEAWAYS

– IRA provisions alone could reduce the federal deficit by $237 billion over 10 years, the Congressional Budget Office has calculated.

– That enormous savings would come from tamping down drug prices, which are costing an average of 3.44 times what the same brand-name drugs cost in other developed countries.

– Without any guardrails, prices for some existing drugs have soared, even as they have fallen sharply in other countries. New drugs have enormous price tags, buttressed by lobbying and marketing.

This article was published on Friday, August 18, 2023 by KFF Health News.

By Elisabeth Rosenthal

Last year’s Inflation...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Insurance, Medicare, Patient / Consumer, Pharma, Pharma / Biotech
New 'how-to guide' for future rapid vaccine development
Infographic: R&D Spending Growth of Top Pharma Companies
Medicare prescription drug pricing variance: 5 things to know
Payer group 'deeply concerned' by Medicare weight loss drug coverage proposal
Adoption Of Model-Informed Drug Development Can Improve Pharma ROI

Share This Article